Compositions for treating heartworm infestation
AssigneeCeva Sante Animale
InventorsPATRICK FORGET, VASSILIOS KALTSATOS, STEPHAN WARIN
Life of this patent
Estimating the term…
Abstract
The present invention further relates to ivermectin, most preferably formulated as an implant for administration of pet and domestic animals. These formulations provide long term protection against Dirofilaria parasites, without the risks for secondary adverse events of conventional formulations. Preferred formulations are implants and are administered at least twice a year, once a year, or at least once in 18 months, up to 24 months.
Claims14
A veterinary drug composition for use in controlling heartworm disease or dirofilariosis in a non-human animal subject, wherein said composition is in the form of an implant said implant releasing ivermectin sufficient to achieve and maintain plasma concentration of ivermectin in the dog between 0.1 ng/mL and 0.15 ng/mL for at least 6 months and up to 24 months after implantation.
A veterinary drug composition for use in controlling Dirofilaria immitis and/or Dirofilaria repens infestation in non-human animal subject, wherein said composition is in the form of an implant, said implant releasing ivermectin sufficient to achieve and maintain plasma concentration of ivermectin in the dog between 0.1 ng/mL and 0.15 ng/mL for at least 6 months and up to 24 months after implantation.
(canceled)
A kit useful in the control of a parasitic infestation of heartworm in a non-human animal subject, which comprises an implant containing an effective dose of ivermectin for controlling Dirofilaria immitis and/or Dirofilaria repens infestation, at a lower plasma concentration of ivermectin of about 5% to 95% as compared to plasma ivermectin concentration obtained via conventional ivermectin formulation, and instructions for the treatment and/or prevention in said subject.
Dependencies are inferred from the claim text.